News & Articles

Booth 1415

KEYTRUDA is Merck's anti-PD-1 therapy for metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy

Twenty-fold increase in sensitivity allows quantification of single cell levels of dsDNA

Booth 1553

Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting

Discover a smartphone app that improves column selection, plus a new method for the quantification of bradykinin in plasma

Take good care of your cells

Professor Paul Cockwell addresses the delegation at the 7th International Binding Site Symposium

All the information you need to make the best purchasing decision

AMSBIO has announced the launch of PATHM2 small molecules libraries for small scale screening in developmental biology and discovery research.